Brimonidine Tartrate And Timolol Maleate Solution/ Drops
Product Images NDC 62332-706

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate And Timolol Maleate (NDC 62332-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimo-timo-10-ml-carton (Brimo Timo 10 mL Carton)

Packaging label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, 10 mL, by Alembic Pharmaceuticals Inc. The label displays the proprietary and generic names, strength, dosage form as ophthalmic drops, and manufacturer information. It includes usage information, preservative and inactive ingredients, storage instructions, and features an eye illustration and Alembic logo.*

FDA Label Image

Brimo-timo-10-ml-container (Brimo Timo 10 mL Container)

Label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, sterile 10 mL drops. The label shows active ingredients, preservative benzalkonium chloride 0.005%, storage instructions, and is manufactured for Alembic Pharmaceuticals, Inc. It is marked Rx only and includes dosing information and lot and expiration placeholders.*

FDA Label Image

Brimo-timo-15-ml-carton (Brimo Timo 15 mL Carton)

The packaging label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, sterile solution/drops by Alembic Pharmaceuticals Inc. It is labeled as prescription only and comes in a 15 mL bottle. The label includes active ingredients, preservative, inactives, usual dosage instructions, storage conditions, and manufacturer information for Alembic Pharmaceuticals Limited, India.*

FDA Label Image

Brimo-timo-15-ml-container (Brimo Timo 15 mL Container)

Packaging label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, containing 0.2% brimonidine tartrate and 0.5% timolol. The label indicates sterility and a 15 mL solution volume. It displays the NDC 62332-706-15 and is manufactured for Alembic Pharmaceuticals, Inc. in New Jersey, USA, with production noted as made in India.*

FDA Label Image

Brimo-timo-5-ml-carton (Brimo Timo 5 mL Carton)

Packaging label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, a sterile eye drop solution. The label indicates a 5 mL bottle, with directions stating Rx only. It includes manufacturer details for Alembic Pharmaceuticals Inc. and Alembic Pharmaceuticals Limited, noting the product is made in India. The label also lists actives, preservative, inactives, and storage conditions.*

FDA Label Image

Brimo-timo-5-ml-container (Brimo Timo 5 mL Container)

Label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5%, 5 mL sterile drops. The label includes dosage strength, preservative information (benzalkonium chloride 0.005%), storage instructions, manufacturing details by Alembic Pharmaceuticals Inc., and areas designated for lot and expiration coding. The label highlights the proprietary name and active ingredients prominently.*

FDA Label Image

Brimo-timo-struc-timolol (Brimo Timo Struc Timolol)

Chemical structure of Brimonidine Tartrate and Timolol Maleate, the active ingredients in the ophthalmic solution.*

FDA Label Image

Brimo-timo-structure-brimonidine (Brimo Timo Structure Brimonidine)

Chemical structure diagram of Brimonidine Tartrate and Timolol Maleate, showing their molecular frameworks including rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.